Published in Pediatrics on January 01, 1984
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ (1985) 2.35
Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr (2008) 1.93
Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol (2002) 1.42
Immunisation of preterm infants. Br Med J (Clin Res Ed) (1986) 1.36
Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J Clin Microbiol (1984) 1.15
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect Immun (2002) 1.05
Accelerated immunisation with diphtheria-tetanus-pertussis vaccine. BMJ (1991) 0.98
Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed (1999) 0.95
Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun (2005) 0.95
Accelerated immunisation with diphtheria-tetanus-pertussis vaccine. BMJ (1991) 0.85
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Palliative and end-of-life care in the African American community. JAMA (2000) 3.62
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition. Cell (1993) 3.39
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Implementation of clinical guidelines using a computer charting system. Effect on the initial care of health care workers exposed to body fluids. JAMA (1997) 2.83
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med (1979) 2.34
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae. Mol Microbiol (1996) 2.30
Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23
Bacterial meningitis and septicemia in sickle cell disease. Am J Dis Child (1977) 2.19
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics (1984) 2.15
Pulse oximetry as a fifth pediatric vital sign. Pediatrics (1997) 2.11
Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes (1977) 2.02
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Efficacy of cervical spine immobilization methods. J Trauma (1983) 1.89
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
Structural determinants of processing and secretion of the Haemophilus influenzae hap protein. Mol Microbiol (1997) 1.83
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Control of early seed development. Annu Rev Cell Dev Biol (2001) 1.81
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol Cell (1998) 1.75
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Emergency medical services and the pediatric patient: are the needs being met? Pediatrics (1984) 1.69
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Genes encoding high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are part of gene clusters. Infect Immun (1994) 1.64
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes. Proc Natl Acad Sci U S A (1999) 1.60
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae. FEMS Microbiol Rev (1999) 1.59
Admission decisions in emergency department chest pain patients at low risk for myocardial infarction: patient versus physician preferences. Ann Emerg Med (1996) 1.58
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story. Microbes Infect (2000) 1.53
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
A comparison of pulse oximetry and respiratory rate in patient screening. Respir Med (1996) 1.51
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
Proposed embryopathic relation between mumps virus and primary endocardial fibroelastosis. N Engl J Med (1966) 1.47
Maturation and secretion of the non-typable Haemophilus influenzae HMW1 adhesin: roles of the N-terminal and C-terminal domains. Mol Microbiol (2000) 1.44
Incorporating patient preferences into practice guidelines: management of children with fever without source. Ann Emerg Med (1994) 1.44
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics (1978) 1.42
Capillary refill--is it a useful predictor of hypovolemic states? Ann Emerg Med (1991) 1.41
Vasopressin levels in infants during the course of aseptic and bacterial meningitis. Am J Dis Child (1991) 1.39
An unexpected complication of heated hose humidification. Anaesth Intensive Care (1994) 1.38
Care of the febrile child: an annotated bibliography. Am J Emerg Med (1991) 1.38
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells. J Immunol (2000) 1.36
Adhesin expression in matched nasopharyngeal and middle ear isolates of nontypeable Haemophilus influenzae from children with acute otitis media. Infect Immun (1999) 1.36
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Depression of tuberculin delayed hypersensitivity by live attenuated mumps virus. J Pediatr (1970) 1.34
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
The significance of anaerobes in neonatal bacteremia: analysis of 23 cases and review of the literature. Pediatrics (1974) 1.28
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatr Infect Dis (1983) 1.23
Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b. J Infect Dis (1978) 1.22
Advance directives. Effect of type of directive on physicians' therapeutic decisions. Arch Intern Med (1993) 1.22
Effect of emergency department information on patient satisfaction. Ann Emerg Med (1993) 1.19
Hyperviscosity syndrome associated with necrotizing enterocolitis. Am J Dis Child (1975) 1.19
The radiologic localization of the major aortic tributaries in the newborn infant. J Pediatr (1972) 1.18
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol (1979) 1.15
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Human rabies. West J Med (1978) 1.12
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Implementation of clinical guidelines via a computer charting system: effect on the care of febrile children less than three years of age. J Am Med Inform Assoc (2000) 1.11
Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10
Quantitative urine culture with calibrated bacteriologic loop: office laboratory technique. Minn Med (1966) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
Povidone-iodine for ophthalmia neonatorum prophylaxis. Am J Ophthalmol (1994) 1.10
Exposure of emergency medicine personnel to ionizing radiation during cervical spine radiography. Ann Emerg Med (1989) 1.09
Intrauterine infection of the rhesus monkey with mumps virus: abbreviated viral replication in the immature fetus as an explanation for split immunologic recognition after birth. J Infect Dis (1972) 1.09
Inulin clearance in the newborn infant: relationship to gestational and postnatal age. Pediatr Res (1976) 1.08
Neonatal risk following late gestational genital herpesvirus hominis infection. Am J Dis Child (1975) 1.08